Recruiting A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010). NCT05947851 Conditions CLL, Chronic Disease, Disease Attributes, +18 more Locations Highlands Oncology Group ( Site 5405) — Springdale, Arkansas, United States MemorialCare Health System - Long Beach Medical Center ( Site 5421) — Long Beach, California, United States Memorial Hospital West ( Site 5410) — Pembroke Pines, Florida, United States Oregon Health and Science University ( Site 5425) — Portland, Oregon, United States View all 55 locations View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting Epcoritamab in Chronic Lymphocytic Leukemia and Richter Syndrome NCT06676033 Conditions Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
